Mural Oncology Statistics

Total Valuation

Mural Oncology has a market cap or net worth of $59.97 million. The enterprise value is -$131.95 million.

Market Cap	59.97M
Enterprise Value	-131.95M

Important Dates

The next estimated earnings date is Tuesday, November 19, 2024, before market open.

Earnings Date	Nov 19, 2024
Ex-Dividend Date	n/a

Share Statistics

Mural Oncology has 17.04 million shares outstanding. The number of shares has increased by 0.51% in one year.

Current Share Class	17.04M
Shares Outstanding	17.04M
Shares Change (YoY)	+0.51%
Shares Change (QoQ)	+0.78%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	46.30%
Float	13.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.30
P/TBV Ratio	0.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.65, with a Debt / Equity ratio of 0.05.

Current Ratio	8.65
Quick Ratio	8.38
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -178.34% and return on invested capital (ROIC) is -96.64%.

Return on Equity (ROE)	-178.34%
Return on Assets (ROA)	-81.05%
Return on Capital (ROIC)	-96.64%
Revenue Per Employee	n/a
Profits Per Employee	-$1.48M
Employee Count	117
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Mural Oncology has paid $6.94 million in taxes.

Income Tax	6.94M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.37
200-Day Moving Average	3.75
Relative Strength Index (RSI)	53.10
Average Volume (20 Days)	65,138

Short Selling Information

The latest short interest is 392,793, so 2.31% of the outstanding shares have been sold short.

Short Interest	392,793
Short Previous Month	465,839
Short % of Shares Out	2.31%
Short % of Float	2.87%
Short Ratio (days to cover)	3.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-171.54M
Pretax Income	n/a
Net Income	-173.30M
EBITDA	-168.40M
EBIT	-171.54M
Earnings Per Share (EPS)	-$10.33

Full Income Statement

Balance Sheet

The company has $204.70 million in cash and $11.08 million in debt, giving a net cash position of $193.62 million or $11.36 per share.

Cash & Cash Equivalents	204.70M
Total Debt	11.08M
Net Cash	193.62M
Net Cash Per Share	$11.36
Equity (Book Value)	204.57M
Book Value Per Share	12.09
Working Capital	188.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$159.89 million and capital expenditures -$2.40 million, giving a free cash flow of -$162.29 million.

Operating Cash Flow	-159.89M
Capital Expenditures	-2.40M
Free Cash Flow	-162.29M
FCF Per Share	-$9.53

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mural Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.51%
Shareholder Yield	-0.51%
Earnings Yield	-290.61%
FCF Yield	-272.15%

Analyst Forecast

The average price target for Mural Oncology is $16.00, which is 354.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	354.55%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2